Bortezomib in Kidney Transplant: Current Use and Perspectives.

Abstract:

BACKGROUND:Despite major advances in transplant medicine, antibody-mediated rejection (AMR) continues to have severe clinical implications and adversely affect graft survival. Therefore, the search for alternative drugs to treat AMR is widely pursued. The first-in-class proteasome inhibitor bortezomib (BZ) is a selective inhibitor of the 26S proteasome, which was initially approved for the treatment of malignant plasma cell disorders. METHODS:This review encompasses how our understanding of inhibiting proteasome pathway created the basis of BZ research and important milestones accomplished in AMR treatment in the transplant setting. It further discusses at length the results of clinical studies, the tolerability profile, drug-drug interactions and the perspectives of BZ use in desensitization protocols. RESULTS:Proteasome inhibition can downregulate NF-κB activity; decrease cell proliferation/differentiation; induce apoptosis via cell cycle arrest, endoplasmic reticulum stress and caspase induction due the accumulation of unfolded or misfolded proteins; and downregulate antigen presentation, cell-cell interaction, and cell migration. Proteasome inhibition is more evident in cells with high rate of protein synthesis and secretion, like plasma cells. These cells play a critical role in the production of antibodies during AMR. CONCLUSIONS:There is accumulating evidence that the proteasome inhibitor BZ may substantially affect the function and integrity of alloantibody-secreting plasma cells in AMR after organ solid transplant, as well as the activation, proliferation and differentiation of T- and B-lymphocytes. Recent clinical studies have provided evidence that BZ has the capability to downregulate circulating antibodies and treat AMR episodes. Additional randomized-controlled studies are required to assess the impact of BZ during short and long follow-ups.

journal_name

Curr Drug Metab

journal_title

Current drug metabolism

authors

Requiao-Moura LR,de Sandes-Freitas TV,Marcelo-Gomes G,Rangel EB

doi

10.2174/1389200218666171121100716

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

1136-1146

issue

12

eissn

1389-2002

issn

1875-5453

pii

CDM-EPUB-87005

journal_volume

18

pub_type

杂志文章,评审
  • HIV-1 reverse transcriptase inhibitors: current issues and future perspectives.

    abstract::One of the major advances in the recent history of the treatment of HIV infections has been the development of different classes of effective antiretroviral drugs. In particular, the reverse transcriptase (RT) inhibitors still represent the majority of the clinically used anti-HIV drugs and constitute the main backbon...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200043335504

    authors: Locatelli GA,Cancio R,Spadari S,Maga G

    更新日期:2004-08-01 00:00:00

  • Safety and tolerability of agomelatine: focus on hepatotoxicity.

    abstract::Hepatotoxicity related to antidepressive pharmacotherapy is a major safety concern, particularly considering that severe forms of hepatic failure with fatal outcome have been reported. Severe hepatotoxic adverse drug reactions were also reported for agomelatine (AGM), an antidepressive agent, which was approved for th...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200215666140926155041

    authors: Gahr M,Kratzer W,Fuchs M,Connemann BJ

    更新日期:2014-01-01 00:00:00

  • Lipid Nanoformulations in the Treatment of Neuropsychiatric Diseases: An Approach to Overcome the Blood Brain Barrier.

    abstract:BACKGROUND:Neuropsychiatric diseases primarily characterized by dementia stand third in the global list of diseases causing disability. The poor water solubility, erratic oral absorption, low bioavailability, poor intestinal absorption, and the impeding action of the blood-brain barrier (BBB) are the major factors limi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1573399816666200627214129

    authors: Rehman S,Nabi B,Pottoo FH,Baboota S,Ali J

    更新日期:2020-01-01 00:00:00

  • Model-based Meta-analysis to Compare Primary Efficacy-endpoint, Efficacy-time Course, Safety, and Tolerability of Opioids Used in the Management of Osteoarthritic Pain in Humans.

    abstract:BACKGROUND:Despite recent therapeutic advances, osteoarthritis continues to be a challenging health problem, especially in the elderly population. Opioids, which are potent analgesics, have shown an extraordinary ability to reduce intense pain in many osteoarthritic clinical trials; however, there is an increased need ...

    journal_title:Current drug metabolism

    pub_type: meta分析

    doi:10.2174/1389200221666200514130441

    authors: Alhaj-Suliman SO,Milavetz G,Salem AK

    更新日期:2020-01-01 00:00:00

  • CYP-mediated clozapine interactions: how predictable are they?

    abstract::Despite the introduction of newer drugs, the atypical antipsychotic clozapine remains the most effective drug in psychotic patients who are resistant to treatment with conventional agents. Optimal therapeutic responses to clozapine have been reported with serum concentrations between 350 microg/L and 1000 microg/L. Cl...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007780655469

    authors: Chetty M,Murray M

    更新日期:2007-05-01 00:00:00

  • Personalized medicine: potential, barriers and contemporary issues.

    abstract::Personalized medicine has gained significant attention over the last decade as technologies for understanding biological differences between individuals have advanced dramatically. There are many potential benefits of personalized medicine including minimizing risk of drug toxicity, increasing benefit from drugs used,...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012802138615

    authors: Sorich MJ,McKinnon RA

    更新日期:2012-09-01 00:00:00

  • Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.

    abstract:BACKGROUND:Glioblastoma multiforme, one of the most aggressive brain tumors, has a very poor clinical outcome. Despite the introduction of the alkylating reagent temozolomide (TMZ) to surgery and radiotherapy, the survival of patients could only be modestly increased up to less than 15 months. Therefore, innovative tre...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160607232540

    authors: Shevtsov M,Multhoff G

    更新日期:2016-01-01 00:00:00

  • Emerging technologies, recent developments, and novel applications for drug metabolite identification.

    abstract::Drug metabolite identification and metabolic characteristics analysis play a crucial role in new drug research and development, because they can lead to varied efficacy, severe adverse reactions, and even toxicity. Classical methodologies for metabolite identification have mainly been based on mass spectrometry (MS) c...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200216666141230105649

    authors: Lu W,Xu Y,Zhao Y,Cen X

    更新日期:2014-01-01 00:00:00

  • Brain metabolism of ethanol and alcoholism: an update.

    abstract::It has long been suggested that some of the neuropharmacological, neurochemical and behavioural effects of ethanol are mediated by its first metabolite, acetaldehyde. In spite of the well documented psychoactivity of acetaldehyde, the precise role of this compound in alcohol abuse remains a matter of intense debate am...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007782109797

    authors: Hipólito L,Sánchez MJ,Polache A,Granero L

    更新日期:2007-10-01 00:00:00

  • Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.

    abstract:BACKGROUND:Clinical studies during pregnancy are rare due to ethical and practical limitations. Giving pregnant females the same dosing regimen used in adult males or nonpregnant females is inappropriate. Pregnancy physiologically-based pharmacokinetic modeling is a powerful tool that can be used to refine pharmacother...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180702104034

    authors: Alsmadi MM,Idkaidek N

    更新日期:2018-01-01 00:00:00

  • How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation.

    abstract::Infection with the human immunodeficiency virus type 1 (HIV) results in a chronic infection that progressively cripples the host immune defenses. HIV infection is associated with increased tryptophan (trp) catabolism by the cytokine-inducible enzyme indoleamine 2,3-dioxygenase (IDO). IDO has powerful immune suppressiv...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007780362527

    authors: Boasso A,Shearer GM

    更新日期:2007-04-01 00:00:00

  • Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?

    abstract:BACKGROUND:Bioequivalence studies are a vital part of drug development. The average bioequivalence approach is the standard method of assessment to conclude whether the generic product is bioequivalent to the innovator product. Of late, debates are on whether the average bioequivalence approach adequately addresses dru...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.2174/1389200221666200401105119

    authors: Micheal F,Sayana M,Prasad R,Motilal BM

    更新日期:2020-01-01 00:00:00

  • Preclinical Pharmacokinetics Study of a Novel Intravenous Anesthetic ET-26 Hydrochloride.

    abstract:BACKGROUND:ET-26 hydrochloride is a novel intravenous anesthetic, approved for clinical trials, that produces a desirable sedative-hypnotic effect with stable myocardial performance and mild adrenocortical suppression in rats and beagle dogs. The objective of this study was to assess the absorption, distribution, metab...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666191223105504

    authors: Zhang YJ,Deng C,Yang J,Gong D,Kang Y,Liu J,Zhang W

    更新日期:2019-01-01 00:00:00

  • Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance.

    abstract:BACKGROUND:Interleukin-28B (IL28B) locus on a human chromosomal region mapped to 19q13 execute immune defense against viruses. During Hepatitis C Virus (HCV) infection the IL28B has a promising role in deciding the consequence of infection for spontaneous clearance of viruses or causing chronic liver infection. Treatme...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180129115359

    authors: Asthana M,Sahu SK,Kumar A,Mohanty S,Chakrabarti S,Das P,Chattopadhya NR,Chatterjee K,Singh SP,Rajasubramaniam S,Choudhuri T

    更新日期:2018-01-01 00:00:00

  • Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.

    abstract::Ophthalmic drugs are delivered to ocular tissues predominantly via relatively simple formulations, such as topically dosed water-soluble drug solutions and water-insoluble drug suspensions in ointments. An ideal topical drug delivery system should possess certain desirable properties, such as good corneal and conjunct...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920007779815977

    authors: Bu HZ,Gukasyan HJ,Goulet L,Lou XJ,Xiang C,Koudriakova T

    更新日期:2007-02-01 00:00:00

  • Atypical antipsychotic metabolism and excretion.

    abstract:BACKGROUND:The metabolic/biotransformation pathways of atypical antipsychotics (aripiprazole, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) have been characterized and reviewed. However, comparisons of excretory pathways remain unexplored. OBJECTIVE:To analyze the excretio...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010791636202

    authors: Sheehan JJ,Sliwa JK,Amatniek JC,Grinspan A,Canuso CM

    更新日期:2010-07-01 00:00:00

  • UGT1A1 Mediated Drug Interactions and its Clinical Relevance.

    abstract:BACKGROUND:The administration of multiple drugs for the treatment of diseases is an integral aspect of modern medicine. Though its purpose is to create the intended therapeutic effect, the unintended consequences of drug interactions can cause severe side effects and subsequent economic losses. Likewise, herbal extract...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200216666151103121253

    authors: Goon CP,Wang LZ,Wong FC,Thuya WL,Ho PC,Goh BC

    更新日期:2016-01-01 00:00:00

  • Immune monitoring in organ transplantation using neopterin.

    abstract::Transplantation has become an established and successful therapy. Rejections and infections are the principal immune-related complications in the post-transplant course. A reliable and early diagnosis is necessary to prevent graft failure and patient morbidity. Despite the immunologic nature of these complications the...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200024605109

    authors: Grebe SO,Mueller TF

    更新日期:2002-04-01 00:00:00

  • A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction.

    abstract::In vitro models of the liver using isolated primary hepatocytes have been used as screens for measuring the metabolism, toxicity and efficacy of xenobiotics, for studying hepatocyte proliferation, and as bioartificial liver support systems. Yet, primary isolated hepatocytes rapidly lose liver specific functions when m...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920005774832632

    authors: Sivaraman A,Leach JK,Townsend S,Iida T,Hogan BJ,Stolz DB,Fry R,Samson LD,Tannenbaum SR,Griffith LG

    更新日期:2005-12-01 00:00:00

  • Herb-Drug Interactions and Hepatotoxicity.

    abstract:BACKGROUND:In recent times, herbals or phytomedicines have become very popular due to their global acceptance as a complementary and alternative remedy. While modern drugs are commercially available only after laboratory validations, clinical trials, as well as approval from drug regulatory authorities, majority of the...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200220666190325141422

    authors: Parvez MK,Rishi V

    更新日期:2019-01-01 00:00:00

  • Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.

    abstract::Brain, the centre of the nervous system and an integral part the body, is protected by two anatomical and physiological barriers- Blood-Brain Barrier (BBB) and Blood-Cerebrospinal Fluid Barrier (BCSFB). Blood-Brain Barrier is a very complex and highly organized multicellular structure that shields the brain from harmf...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200218666170113125132

    authors: Sarkar A,Fatima I,Jamal QMS,Sayeed U,Khan MKA,Akhtar S,Kamal MA,Farooqui A,Siddiqui MH

    更新日期:2017-01-01 00:00:00

  • Functional expression of human cytochrome P450 enzymes in Escherichia coli.

    abstract::Knowledge regarding cytochrome P450 (P450) is crucial to the fields of drug therapy and drug development, as well as in our understanding of the mechanisms underlying the metabolic activation of potentially toxic and carcinogenic compounds. Escherichia coli is the most extensively utilized host in the production of re...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006776873472

    authors: Yun CH,Yim SK,Kim DH,Ahn T

    更新日期:2006-05-01 00:00:00

  • Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs.

    abstract::In the recent decades, the use of herbal products has been rapidly growing in the Western countries. While their use in many cases causes adverse effects, to date, safety issues of herbal products have not been adequately addressed. It is rarely determined whether the non-purported bioactive constituents in the herbs ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011797470119

    authors: Li N,Xia Q,Ruan J,Fu PP,Lin G

    更新日期:2011-11-01 00:00:00

  • The role of organic ion transporters in drug disposition: an update.

    abstract::Transporters for organic anions and organic cations in kidney, liver, intestine, brain, and placenta play essential roles in drug disposition. The cloning and characterization of these transporters have significantly advanced our understanding of the molecular and cellular mechanisms of the drug disposition process. T...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200043489207

    authors: You G

    更新日期:2004-02-01 00:00:00

  • Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies.

    abstract:BACKGROUND:Painful peripheral neuropathy is a dose-limiting adverse effect of the antitumor drug oxaliplatin. The main symptoms of neuropathy: tactile allodynia and cold hyperalgesia, appear in more than 80% of patients on oxaliplatin therapy and are due to the overexpression of neuronal sodium channels (Navs) and neur...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666200711155632

    authors: Furgała-Wojas A,Kowalska M,Nowaczyk A,Fijałkowski Ł,Sałat K

    更新日期:2020-01-01 00:00:00

  • Oral L-carnitine: metabolite formation and hemodialysis.

    abstract::L-Carnitine has important roles in intermediary metabolism and patients with end-stage renal disease who are undergoing hemodialysis may develop a secondary L-carnitine deficiency. The extent of accumulation of the metabolites trimethylamine and trimethylamine-N-oxide when L-carnitine is administered orally has not be...

    journal_title:Current drug metabolism

    pub_type: 临床试验,杂志文章

    doi:10.2174/138920006778520561

    authors: Bain MA,Faull R,Milne RW,Evans AM

    更新日期:2006-10-01 00:00:00

  • Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

    abstract::5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) belongs to a group of naturally-occurring psychoactive indolealkylamine drugs. It acts as a nonselective serotonin (5-HT) agonist and causes many physiological and behavioral changes. 5-MeO-DMT is O-demethylated by polymorphic cytochrome P450 2D6 (CYP2D6) to an active metab...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010794233495

    authors: Shen HW,Jiang XL,Winter JC,Yu AM

    更新日期:2010-10-01 00:00:00

  • A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.

    abstract:BACKGROUND:In the last few years, the use of modified Carbon Nanomaterials (CNMs) for theranostics (therapeutic and diagnosis) applications is a new and rapidly growing area in pharmacy and medical fields. Owing to this, their specific physicochemical behaviors like high stability, drug loading, surface area to volume ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180925094515

    authors: Gupta N,Rai DB,Jangid AK,Kulhari H

    更新日期:2019-01-01 00:00:00

  • Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.

    abstract::Bioavailability of orally administered drugs can be influenced by a number of factors including release from the formulation, dissolution, stability in the gastrointestinal (GI) environment, permeability through the gut wall and first-pass gut wall and hepatic metabolism. Although there are various enzymes in the gut ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920010794328913

    authors: Darwich AS,Neuhoff S,Jamei M,Rostami-Hodjegan A

    更新日期:2010-11-01 00:00:00

  • Electroporation in DNA vaccination protocols against cancer.

    abstract::Since conventional therapeutic approaches in cancer are highly invasive they hardly prolong patient survival for more than few months. Having the ability to stimulate both cellular and humoural immune responses, immunisation with naked plasmid DNA encoding tumour-associated antigens or tumour-specific antigens has rec...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200211314030004

    authors: Chiarella P,Fazio VM,Signori E

    更新日期:2013-03-01 00:00:00